Inspire Veterinary Partners Files 8-K

Ticker: IVPR · Form: 8-K · Filed: Dec 30, 2025 · CIK: 1939365

Inspire Veterinary Partners, Inc. 8-K Filing Summary
FieldDetail
CompanyInspire Veterinary Partners, Inc. (IVPR)
Form Type8-K
Filed DateDec 30, 2025
Risk Levelmedium
Pages2
Reading Time3 min
Key Dollar Amounts$0.0001, $150,000, $0.05
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, equity-sale, financials

TL;DR

Inspire Vet Partners signed a big deal, sold some stock, and filed financials on Dec 18.

AI Summary

Inspire Veterinary Partners, Inc. entered into a Material Definitive Agreement on December 18, 2025. The company also reported on unregistered sales of equity securities and filed financial statements and exhibits. The exact nature of the agreement and the details of the equity sales are not specified in this filing.

Why It Matters

This filing indicates significant corporate activity, including a material agreement and equity transactions, which could impact the company's financial standing and future operations.

Risk Assessment

Risk Level: medium — The filing mentions a material definitive agreement and unregistered sales of equity securities, which can introduce financial and regulatory risks if not properly managed.

Key Players & Entities

  • INSPIRE VETERINARY PARTNERS, INC. (company) — Registrant
  • December 18, 2025 (date) — Date of earliest event reported
  • Nevada (jurisdiction) — State of incorporation
  • 001-41792 (identifier) — Commission File Number
  • 85-4359258 (identifier) — I.R.S. Employer Identification No.
  • 780 Lynnhaven Parkway , Suite 400 Virginia Beach , VA 23452 (address) — Address of principal executive offices
  • ( 757 ) 734-5464 (phone_number) — Registrant's telephone number

FAQ

What is the nature of the Material Definitive Agreement entered into by Inspire Veterinary Partners, Inc. on December 18, 2025?

The filing does not specify the details of the Material Definitive Agreement, only that one was entered into on December 18, 2025.

What type of equity securities were sold in the unregistered sales reported by Inspire Veterinary Partners, Inc.?

The filing mentions unregistered sales of equity securities but does not provide specific details about the type of securities sold.

What are the key financial highlights or figures presented in the filed financial statements?

The filing indicates that financial statements and exhibits were filed, but the specific financial figures are not detailed in the provided text.

When was the Form 8-K filed with the SEC?

The Form 8-K was filed as of December 30, 2025, with the date of the earliest event reported being December 18, 2025.

What is Inspire Veterinary Partners, Inc.'s state of incorporation and principal executive office location?

Inspire Veterinary Partners, Inc. is incorporated in Nevada and its principal executive offices are located at 780 Lynnhaven Parkway, Suite 400, Virginia Beach, VA 23452.

Filing Stats: 662 words · 3 min read · ~2 pages · Grade level 10.4 · Accepted 2025-12-29 18:13:35

Key Financial Figures

  • $0.0001 — ch registered Common stock, par value $0.0001 IVP Nasdaq Capital Market Indicat
  • $150,000 — the Company and Target agreed to cancel $150,000 of the outstanding principal amount und
  • $0.05 — mined by dividing the cancelled debt by $0.05 per share. The exchange was effected i

Filing Documents

01. Entry into a Material Definitive Agreement

Item 1.01. Entry into a Material Definitive Agreement. On December 18, 2025, Inspire Veterinary Partners, Inc. (the "Company"), entered into a Cancellation and Exchange Agreement, (the "Agreement") between the Company and Target Capital 1 LLC ( "Target"). Pursuant to the Agreement, the Company and Target agreed to cancel $150,000 of the outstanding principal amount under that certain promissory note issued by the Company to Target on June 10, 2025, as amended (the "June Note"), in exchange for 3,000,000 shares of the Company's Class A common stock, par value $0.0001 per share (the "Common Stock"). The number of shares issued was determined by dividing the cancelled debt by $0.05 per share. The exchange was effected in reliance on the exemption from registration provided by Section 3(a)(9) of the Securities Act of 1933, as amended (the "Securities Act"). The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of such agreement, a copy of which is furnished as Exhibit 10.1 to this Report on Form 8-K.

02 Unregistered Sales of Equity Securities

Item 3.02 Unregistered Sales of Equity Securities. The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference herein. The offer of securities to Target pursuant to the Agreement is being conducted as a private placement pursuant to and in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act, and/or Rule 506(b) of Regulation D promulgated thereunder for transactions not involving a public offering and the exchange of the June Note is being conducted in reliance on Section 3(a)(9) of the Securities Act. Item. 9.01. Financial Statements and Exhibits Exhibit No. Description 10.1 Cancellation and Exchange Agreement, dated December 18, 2025, between Inspire Veterinary Partners, Inc. and Target Capital 1 LLC. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 29, 2025 INSPIRE VETERINARY PARTNERS, INC. By: /s/ Kimball Carr Name: Kimball Carr Title: President and Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.